Sept 13 (Reuters) - U.S. biotech firm Genzyme Corp (GENZ.O) said it agreed to sell its genetic-testing business to Laboratory Corp of America Holdings (LH.N) for $925 million in cash.
Sept 13 (Reuters) - U.S. biotech firm Genzyme Corp (GENZ.O) said it agreed to sell its genetic-testing business to Laboratory Corp of America Holdings (LH.N) for $925 million in cash.
